Consolidated EdisonNYSE: ED

Low beta stocks can offer stabilization when combined with high-beta stocks, providing a more balanced risk profile.

Here is how Consolidated Edison (ED) and PPL (PPL) have performed compared to their sector so far this year.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

In ED patients that do not respond to PDE5i monotherapy ~30-40% of ED patients do not respond to PDE5i treatment Data from this Phase 2 clinical study is expected by end of calendar year 2024 Published clinical data and mechanisms of action support clinical study of bremelanotide in combination with a PDE5i Phase 3 clinical study with new co-formulated bremelanotide plus a PDE5i in ED patients that do not respond to PDE5i monotherapy expected to start in the 1st half of calendar year 2025 CRANBURY, N.J. , June 20, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, announced the initiation of a Phase 2 clinical study of bremelanotide (BMT), a melanocortin 4 receptor (MC4R), co-administered with a phosphodiesterase 5 inhibitor (PDE5i), for the treatment of erectile dysfunction (ED) in patients that do not respond to PDE5i monotherapy.

Con Ed (ED) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

NEW YORK , June 10, 2024 /PRNewswire/ -- Consolidated Edison, Inc. (Con Edison) (NYSE: ED) and Consolidated Edison Company of New York, Inc. (CECONY) today announced that Robert Hoglund plans to retire from the role of the Chief Financial Officer on July 8, 2024, and will continue to serve as Senior Vice President of Con Edison and CECONY to provide for a smooth transition until his retirement later in 2024.  As part of the company's succession plan, Kirkland B.

Although the financial results of Con Ed (ED) for the quarter ending March 2024 provide an overview of the company's performance, it may be beneficial to also analyze how certain key metrics measure up against both Wall Street forecasts and the figures from the same period last year.

Consolidated Edison (ED) reported quarterly earnings of $2.15 per share, surpassing the Zacks Consensus Estimate of $1.89 per share. In the same quarter last year, the company had earnings of $1.83 per share.

Consolidated Edison's (ED) first quarter earnings are expected to show the positive effects of increased rates, despite the challenges posed by unseasonably warm weather.